| Document |
Document Title |
|
WO/2013/068275 |
The invention concerns a polymer-bonded polycyclic aromatic hydrocarbon compound of general formula (1): (P—O) x —Q—(Y) w (1) wherein P represents a polymeric moiety having at least three repeating units which comprise an optionall...
|
|
WO/2013/070998 |
Methods for inhibiting the growth of ovarian cancer cells or other serosal cancer cells are disclosed. The method involves exposing the cells to a 2-amino-4H-naphtho[1,2-b]pyran-3-carbonitrile of formula. (I). wherein Y is CR1 or N and Z...
|
|
WO/2013/066067 |
Disclosed are a phenol monomer, a polymer for forming a resist underlayer film including same, and a composition for a resist underlayer film including same, which are to be used in a semiconductor lithography process. The phenol monomer...
|
|
WO/2013/061999 |
Provided is a method for producing an optically active alcohol with high yield by an industrially advantageous process with use of a low-cost asymmetric catalyst, while using a ketone, which may have various structures, as a starting mat...
|
|
WO/2013/058644 |
The invention relates to the use of delphinidin and the derivatives thereof to prepare a drug for treating prediabetes and diabetes. Said drug has the effect of lowering plasma glucose concentration following administration. Said drug in...
|
|
WO/2013/055647 |
Provided are various compounds comprising the formula Also provided are fluorescent dyes comprising the above compound. Additionally, a fluorescence energy transfer system is provided that comprises the above-described fluorescent dye an...
|
|
WO/2013/052338 |
The present invention relates to photochromic materials that include certain indeno-fused naphthopyrans. The indeno-fused naphthopyrans have an amino group (e.g., a piperidino or morpholino group) bonded to the 6-position and hydrogen or...
|
|
WO/2013/045115 |
The invention relates to a compound selected from the group consisting of all stereoisomers and their mixtures of the compounds of general formulas (1)-(4), in which R1 is a straight-chained, branched or cyclic hydrocarbon group with up ...
|
|
WO/2013/048334 |
The present invention relates to use of a series of compounds and compositions comprising the same for enhancing telomerase expression and/or activating telomerase activity in a cell or tissue of a subject and for treatment of diseases, ...
|
|
WO/2013/044118 |
This invention relates to novel coumarin derivatives, formulations comprising same, and to methods of making and using these compounds and formulations, which are useful as repellents against insects and/or pests. The compounds also prev...
|
|
WO/2013/041655 |
Disclosed is a process for the preparation of a cinchonidine salt of formula (IV) via an aqueous solution of a racemic 4-hydroxy-1,2-cyclopentanedicarboxylic acid, which is subjected to cyclization without removing water, by the addition...
|
|
WO/2013/041895 |
The invention relates to novel compounds of general formula (I), and their preparation, pharmaceutical preparations containing compounds of general formula (I), and the use of these compounds in therapeutic procedures. The invention also...
|
|
WO/2013/042800 |
Provided is a chromene compound which has a sulfur-containing substitute represented by formula (2) at the carbon atom in the 6-position and/or the 7-position of an indeno(2,1-f)naphtho(1,2-b)pyran structure. This chromene compound has e...
|
|
WO/2013/034756 |
The present invention relates to a compound of formula (I), wherein R1 and R2 are independently selected from (a) C1 to C6 alkyl; C2 to C6 alkenyl; C2 to C6 alkynyl; substituted or unsubstituted heterocycloalkyl or cycloalkyl, substituen...
|
|
WO/2013/036207 |
The present invention relates to xanthone analogs. Such compounds may be used in the treatment of bacterial infections.
|
|
WO/2013/036678 |
The present invention provides compounds of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1 is as defined and described herein, compositions thereof, and methods of using the same.
|
|
WO/2013/036726 |
Methods for the production of enriched plant polyphenols-dairy (e.g., milk) or polyphenols-ground edible material products that can be used in the preparation of functional foods, dietary supplements, medical foods, cosmetic products or ...
|
|
WO/2013/035767 |
Provided is a compound represented by formula (I), which can be used as a fluorescent probe that becomes highly fluorescent only in an intracellular acidic environment and can be adapted to the fluorescent imaging of an intracellular ves...
|
|
WO/2013/033377 |
Disclosed are novel isoflavone derivatives having the structure of Formula (I) which are ALDH-2 inhibitors, useful for treating a patient in need thereof, for dependence upon drugs of addiction, for example addiction to dopamine-producin...
|
|
WO/2013/031831 |
In the present invention, a method using a combination of iguratimod or a salt thereof and one or more immunosuppressants is useful as a method for the treatment of autoimmune diseases, and with this method adverse effects are lessened. ...
|
|
WO/2013/032608 |
The present invention relates to compounds represented by the following Formulas (I) and (II), Ring-A of Formulas I and II can be, for example, an aryl group, and Q' and Q''' can each be independently selected from groups, such as, halog...
|
|
WO/2013/026149 |
A compound dimethyl-(3,3-difluoro-2,2-dihydroxyheptyl)phosphonate (I), a crystalline form of this compound, processes for its preparation, and use of this compound in the preparation of prostaglandin derivatives such as Lubiprostone.
|
|
WO/2013/024779 |
Provided is a novel underlayer film-forming material and such for lithography, said material having a high carbon concentration and a low oxygen concentration, and exhibiting relatively high heat resistance and solvent solubility. Moreov...
|
|
WO/2013/024778 |
A resist composition containing a compound represented by general formula (1) or (2), a resist pattern formation method using said resist composition, a polyphenol compound used in the resist pattern formation method, and an alcohol comp...
|
|
WO/2013/021971 |
[Problem] To provide an organic photoelectric conversion element whereby conversion efficiency is increased by morphology reformation in a power generation layer, and whereby short-circuit current (Jsc) attenuation when emitting light is...
|
|
WO/2013/020930 |
The present invention relates to aminochromane, aminothiochromane and 1,2,3,4-tetrahydroquinoline derivatives of the formula (I), or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprisin...
|
|
WO/2013/020184 |
Disclosed herein are flavonoid compounds of formula (I) with variables as defined herein, compositions containing these compounds, methods for their synthesis, and uses of these compounds. In particular, there is provided methods of prev...
|
|
WO/2013/020184 |
Disclosed herein are flavonoid compounds of formula (I) with variables as defined herein, compositions containing these compounds, methods for their synthesis, and uses of these compounds. In particular, there is provided methods of prev...
|
|
WO/2013/020979 |
The present invention relates generally to catechin and epicatechin conjugates of formula (I). For example, a chemical synthesis process for the preparation of catechin and epi-catechin compounds, in particular of catechin and epi-catech...
|
|
WO/2013/019686 |
Small molecule therapeutics for the treatment of parasitic diseases, in particular, semi-synthetic derivatives of the fugally-derived natural product merulin A for the treatment of African Sleeping Sickness.
|
|
WO/2013/017071 |
Disclosed are alicyclic[c] benzopyrone derivatives and uses thereof. The said alicyclic[c] benzopyrone derivatives are compounds represented by formula I or their salts. The present compounds not only significantly improve high activity ...
|
|
WO/2013/017063 |
The polymorphic forms of the compound of Formula I, the preparation thereof including the preparation of the intermediates, the pharmaceutical compositions thereof and the uses of a polymorph above in the manufacture of medicaments for t...
|
|
WO/2013/018053 |
The present invention relates to a novel process of synthesis of epoxides, 6-fluoro-2- (oxiran-2-yl) chroman (Figure 1), intermediates for the synthesis of nebivolol, depicted in Scheme (1), enabling to obtain the above- mentioned epoxid...
|
|
WO/2013/018104 |
A process for the extraction of Vitamin E from annatto plant matter is disclosed wherein annatto seed matter is subjected, before extraction, to acidification using amla fruit matter. After the acidification, the mixture of the two plant...
|
|
WO/2013/018104 |
A process for the extraction of Vitamin E from annatto plant matter is disclosed wherein annatto seed matter is subjected, before extraction, to acidification using amla fruit matter. After the acidification, the mixture of the two plant...
|
|
WO/2013/019686 |
Small molecule therapeutics for the treatment of parasitic diseases, in particular, semi-synthetic derivatives of the fugally-derived natural product merulin A for the treatment of African Sleeping Sickness.
|
|
WO/2013/017068 |
Disclosed are a substituted benzopyran derivative and the use thereof. The substituted benzopyran derivative has the structure of formula (I). It has been found in experiments that the derivative can be used to prepare drugs for treating...
|
|
WO/2013/014370 |
The subject matter of the invention is a novel compound obtained from molecules of the coumarin family, which exhibits rodenticidal activity. The invention also relates to the compositions which incorporate such compounds and also to the...
|
|
WO/2013/013078 |
A method of producing alpha-tocotrienol quinone or a stereoisomer thereof, the method comprising selective opening of alpha-tocotrienol chroman to alpha-tocotrienol quinone in the presence of non-alpha tocotrienol chromans by oxidizing a...
|
|
WO/2013/012049 |
Provided are a medicinal agent and a food product, both of which prevent heart diseases such as cardiomegaly and heart failure. Specifically provided is an agent for preventing a heart disease such selected from among heart failure, card...
|
|
WO/2013/002879 |
The invention provides methods and compositions for inhibiting CD 38 activity, and methods of treating or preventing various disorders associated with CD38 activity.
|
|
WO/2013/000275 |
Disclosed are compounds as shown as general formula (I), derivatives and uses thereof, wherein R1, R2, R3, R4, R5a, R5b, R5c and X have the definition as same as the description.
|
|
WO/2013/003815 |
Embodiments of near-infrared (NIR) dyes are disclosed, along with methods and kits for detecting analytes with the NIR dyes. The NIR dyes have a structure according to the general structure (I). At least one of R1/R2, R2/R3, R3/R4, R5/R6...
|
|
WO/2013/003168 |
This invention relates to novel coumarin derivative, formulations comprising same, and to methods of making and using these compounds and formulations, which are useful as repellents against insects and/or pests. The compounds also preve...
|
|
WO/2013/000846 |
The invention relates to a method for producing cyclic enol ethers of formulas (I) and/or (II).
|
|
WO/2012/174622 |
The present invention relates to a plant extract obtained from Kielmeyera aureovinosa which has pronounced antibiotic activity. In a second embodiment, the invention describes a novel chemical compound that is isolated from same, and als...
|
|
WO/2012/176856 |
To provide a novel pesticide. The present invention provides a compound represented by the formula (I) or its salt, and a pesticide containing it as an active ingredient: (I) wherein each of R1 and R2 is a hydrogen atom, a halogen atom, ...
|
|
WO/2012/176918 |
Specifically provided is a chromene compound represented by formula (1), which has a short fading half-life even at low temperatures in a common polymer solid matrix. (In formula (1), R1 represents a hydroxyl group or the like; each of R...
|
|
WO/2012/171652 |
The present invention relates to methods for synthesizing vitamin E, and to intermediates thereto.
|
|
WO/2012/171488 |
The present invention relates to a coumarin derivative of formula (I): wherein X, Y1, Y2, Y3, R1, R2, R3 and R4 are as defined herein, or a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a phar...
|
